Clinical Trials Insight: 700020426
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2008
At a glance
- Drugs Tivozanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors AVEO Oncology
- 09 Apr 2008 Full results will be reported at AACR 2008.
- 07 Nov 2007 Postive results have been reported.
- 07 Nov 2007 Status changed from in progress to completed.